Invesaro

Stocks AIN Financial statements

Financial statements

ALBANY INTERNATIONAL CORP /DE/ financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data ALBANY INTERNATIONAL CORP /DE/ files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue7808649821,0549019291,0351,1481,2311,183
Cost of revenue479567633656530551645724829939
Gross profit301296350398371378390424402244
Research and development28.830.729.826.925.838.939.940.6
Selling, general and administrative158163156164164160169215211218
General and administrative53.756.873.1
Operating income94.178.7137194166178181168131-36.1
Interest expense15.518.620.219.716.317.417.820.216.625.8
Interest income2.081.512.122.732.752.53.846.574.065.16
Other non-operating income-2.4-6.88-4.041.56-13.4-3.0214.16.16-1.72-5.08
Pre-tax income78.354.7115178139166132160117-61.8
Income tax25.522.132.244.841.847.235.548.829-4.83
Net income to minority interests0.08-0.530.130.99-1.350.290.750.490.430.38
Net income52.733.182.913298.611895.811187.6-57.3
EBITDA16215121626423925225024522151.8
EPS, basic1.641.032.574.103.053.663.063.562.81-1.94
EPS, diluted1.641.032.574.103.053.653.043.552.80-1.94
Shares, basic (weighted)32.132.232.332.332.332.331.331.231.229.6
Shares, diluted (weighted)32.232.232.332.332.432.531.531.331.329.6
Dividend per share0.680.680.690.730.770.810.881.011.051.09

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents182184198196241302292173115112
Receivables171203223218188192200288247235
Inventory13413785.995.1110118139170146122
Other current assets9.2514.521.324.131.832.45153.937.135
Total current assets501544593618717759838878731929
Property, plant and equipment423454462466449436446602563483
Lease right-of-use assets18.217.714.448.550.861.711.4
Goodwill160167164181188182178180176163
Intangible assets66.555.449.252.946.939.133.844.638.121.4
Other non-current assets29.839.541.662.974.781.410310311154.9
Total assets1,2631,3611,4181,4741,5501,5561,6421,8351,6491,719
Accounts payable43.344.952.265.249.26969.787.166.164.5
Accrued liabilities95.2106129126125124126143142139
Deferred revenue9.035.668.216.9615.27.136.0933.4
Short-term debt51.71.81.220.020.01004.2200
Total current liabilities200162189203191208211249226442
Long-term debt433514524424398350439453319456
Lease liabilities14.413.61150.250.661.17.42
Other non-current liabilities10710288.313313010810913913986.9
Total liabilities752788810772730678775868700987
Total debt485516525424398350439457319456
Paid-in capital426428431433434437442448453460
Retained earnings5235345906987718639311,0111,066976
Treasury stock-257-257-257-256-256-280-365-365-379-567
Other comprehensive income-184-136-158-176
Shareholders' equity508570605699816874863961944726
Minority interests3.773.253.034.013.83.644.495.955.415.89
Total equity511573608703820878868967949732
Total liabilities and equity1,2631,3611,4181,4741,5501,5561,6421,8351,6491,719
Shares outstanding32.132.232.332.332.332.131.131.231.1

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income52.832.68313397.211996.511288.1-57
Depreciation and amortization67.5727970.872.774.36976.789.387.9
Stock-based compensation6.944.7210.1
Deferred income tax1.57-0.485.3712.411.511.8-8.04-4.3-12.4-36.3
Change in receivables-12.7-21.9-19.79.2831.5-7.73-14.3-1131.8-0.72
Change in inventory-12.53.09-0.97-8.92-13.7-9.94-24.515.114.617.6
Change in payables2.112.919.3410.5-15.69.498.57-5.67-3.089.17
Cash from operations80.964.2132200140217128148218152
Capital expenditures-71.2-85.5-81.6-67.4-41.5-52.8-93.7-83.6-80.2-69.8
Acquisitions-1870-30.8000-13300
Cash from investing-254-87.6-82.9-98.7-42.4-53.7-96.3-218-80.2-68.3
Debt issued236115264575816278146272
Debt repaid-34.4-84-29.9-120-101-56-73-92.3-280-147
Stock issued0.520.60.20.110.060.150.0200
Share buybacks00-23.4-84.80-14.2-186
Dividends paid-21.8-21.9-21.9-23.3-24.6-25.9-26.5-31.2-32.5-32.5
Cash from financing17212.9-27.3-100-60.7-99.6-23.7-52.6-184-96.1
Exchange rate effect-2.812.5-8.31-3.518.58-3.42-18.54.13-12.68.91
Net change in cash-3.371.9914-2.2245.860.7-10.3-118-58.1-2.93
Free cash flow9.7-21.350.913398.816534.564.513882.6
Interest paid13.71618.817.415.114.91618.714.724.6
Income taxes paid23.423.728.125.925.132.55054.547.342,438

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $60.98 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin21.1%Gross profit / revenue.
Operating margin-2.4%Operating income / revenue.
EBITDA margin4.0%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin-4.1%Pre-tax income / revenue.
Net margin-4.2%Net income / revenue.
FCF margin4.8%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin9.9%Cash from operations / revenue.
Return on equity (ROE)-6.9%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)-3.0%Net income / average total assets.
Return on invested capital (ROIC)-2.1%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue18.0%Selling, general and administrative expense / revenue.
Capex / revenue5.0%Capital expenditures / revenue.
D&A / revenue6.4%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y-3.9%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y4.6%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y5.6%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y-39.3%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y-14.5%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y-8.0%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y-127.5%Operating income vs the same period a year earlier. Only from a positive base.
EBITDA growth, 1y-76.5%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y-40.8%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y-26.3%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y-165.4%Net income vs the same period a year earlier. Only from a positive base.
EPS growth, 1y-169.3%EPS vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y-30.2%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y5.9%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y1.7%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y-40.2%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y33.8%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y-3.5%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y3.8%Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y7.4%Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y7.2%Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y-23.0%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y-5.6%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y-2.3%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y4.2%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y1.5%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y2.1%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y-5.7%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y-2.0%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y-1.8%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio2.24xCurrent assets / current liabilities.
Quick ratio0.78x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.18x(Cash + short-term investments) / current liabilities.
Debt / equity0.60xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets26.3%Total debt / total assets.
Liabilities / assets56.1%Total liabilities / total assets.
Net debt$373.3MTotal debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA7.68xNet debt / EBITDA (twelve months), when EBITDA is positive.
Working capital$520.7MCurrent assets - current liabilities.
Goodwill and intangibles / assets10.5%(Goodwill + intangible assets) / total assets.
Tangible book value$565.5MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.71xRevenue / average total assets.
Fixed asset turnover2.62xRevenue / average property, plant and equipment.
Inventory turnover6.61xCost of revenue / average inventory.
Days inventory55 days365 x average inventory / cost of revenue.
Receivables turnover4.85xRevenue / average receivables.
Days sales outstanding75 days365 x average receivables / revenue.
Days payables28 days365 x average accounts payable / cost of revenue.
Cash conversion cycle102 daysDays inventory + days sales outstanding - days payables.
Capex / operating cash flow51.0%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted-$1.79Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$42.80Revenue / diluted weighted shares.
FCF per share$2.07Free cash flow / diluted weighted shares.
Operating cash flow per share$4.22Cash from operations / diluted weighted shares.
Book value per share$26.08Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$19.78Tangible book value / shares outstanding.
Cash per share$2.71(Cash + short-term investments) / shares outstanding.
Dividends / FCF53.5%Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF110.8%Share buybacks / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$1.73BShare price x shares outstanding.
Enterprise value$2.11BMarket cap + total debt - cash - short-term investments.
P/S1.42xMarket cap / revenue.
P/B2.32xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book3.06xMarket cap / tangible book value, when positive.
P/FCF29.3xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF14.4xMarket cap / cash from operations, when positive.
EV/Sales1.72xEnterprise value / revenue.
EV/EBITDA43.3xEnterprise value / EBITDA, when both are positive.
EV/FCF35.6xEnterprise value / free cash flow, when both are positive.
FCF yield3.4%Free cash flow / market cap.
Earnings yield-3.0%Net income / market cap (the inverse of P/E).
Dividend yield1.8%Dividends paid over the period / market cap.
Shareholder yield5.6%(Dividends paid + share buybacks) / market cap.
What was ALBANY INTERNATIONAL CORP /DE/'s revenue in fiscal 2025?

ALBANY INTERNATIONAL CORP /DE/ reported revenue of $1.18B for fiscal 2025, 3.9% lower than the year before.

Was ALBANY INTERNATIONAL CORP /DE/ profitable in fiscal 2025?

No. It reported a net loss of $57.3M.

How much free cash flow did ALBANY INTERNATIONAL CORP /DE/ generate in fiscal 2025?

Cash from operations of $152.5M minus capital expenditures of $69.8M left free cash flow of $82.6M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to ALBANY INTERNATIONAL CORP /DE/